Becker's Healthcare November 26, 2024
Rylee Wilson

The White House is pitching broader coverage of weight loss drugs for millions of Americans on Medicare and Medicaid.

The proposal would expand coverage for weight loss drugs to an estimated 3.4 million Medicare beneficiaries, according to a Nov. 26 news release.

Here are 10 things to know about the proposal:

  1. Currently, Medicare only covers weight loss drugs to treat diabetes or other conditions. A handful of state Medicaid programs already choose to pay for weight loss drugs.
  2. GLP-1s, including Wegovy and Ozempic, can cost over $1,000 a month without insurance coverage.
  3. Medicare coverage of the drugs could cost the federal government $35 billion by 2034, according to estimates published by the Congressional Budget Office...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Insurance, Medicaid, Medicare, Patient / Consumer, Pharma / Biotech, Provider
Related Articles:
JP Morgan Annual Healthcare Conference 2025: What are the key talking points likely to be?
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
New Proposal Aims to Expand Medicaid and Medicare Coverage for Obesity Drugs
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more

Share This Article